Latest Breaking News On - Biologics license application - Page 22 : comparemela.com

Celltrion USA announces two-year data for ZYMFENTRA™(infliximab-dyyb) to be presented at Digestive Disease Week (DDW) 2024 Conference

/PRNewswire/ Celltrion USA today announced it will present the two-year results from the extended LIBERTY studies (LIBERTY-CD and LIBERTY-UC) in adult.

United statesNew jerseyNam leeSarah amundsenAmerican society for gastrointestinal endoscopyPublic health service actSociety for surgery of the alimentary tractAmerican gastroenterological associationDigestive diseaseMedical directorCelltrion united statesOral presentationDigestive disease weekAmerican associationLiver diseasesAmerican society

Autolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates

Longer follow up and subset analyses from the pivotal FELIX Phase 2 data to be presented in oral presentations at ASCO and EHATwo patients enrolled in Phase 1 Systemic Lupus Erythematosus trial;.

United kingdomUnited statesCity ofJulia wilsonJune decSusana noonanOlivia manserRavi raoJohnh johnsonEuropean medicines agencyUniversity college londonEuropean hematology associationCardinal healthNature communicationsSa noonan communicationsAmerican society of clinical oncology

Autolus Therapeutics plc: Autolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates

Autolus Therapeutics plc: Autolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomCity ofUnited statesSusana noonanJohnh johnsonOlivia manserRavi raoJune decJulia wilsonEuropean hematology associationAmerican society of clinical oncologyCardinal healthExchange commissionEuropean medicines agencySa noonan communicationsNature communications

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Blue

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Blue
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesJosh wilsonJames josh wilsonPrnewswire faruqiDrug administrationLitigation partner jamesClass periodBiologics license application

FDA Drug Approval Decisions Expected in June 2024

FDA Drug Approval Decisions Expected in June 2024
psychiatryadvisor.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from psychiatryadvisor.com Daily Mail and Mail on Sunday newspapers.

Drug administrationInternational prognostic scoring systemPrescription drug user fee actNew drug applicationBiologics license applicationPriority reviewPrimary biliaryAdvanced small cell lungLower risk myelodysplasticMaintenance treatment